Home › Funds › Two Sigma Investments › ENOV
Two Sigma Investments position in ENOV
ENOVIS CORPORATION · Health Care
Latest position (Q3 2024)55.64K sh
Reported value held$2.40M
Portfolio Weight0.01%
First reportedQ3 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2022 | 108.60K | $5.00M | New |
| Q2 2023 | 47.02K | $3.01M | New |
| Q3 2023 | 15.39K | $811.57K | Reduce |
| Q4 2023 | 176.98K | $9.91M | Add |
| Q1 2024 | 201.97K | $12.61M | Add |
| Q2 2024 | 50.90K | $2.30M | Reduce |
| Q3 2024 | 55.64K | $2.40M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ENOV
- BlackRock Inc 10.30M sh · $213.12M · Q2 2026
- Vanguard Group 6.44M sh · $171.52M · Q4 2025
- UBS Group AG 2.82M sh · $58.48M · Q2 2026
- Fidelity Management & Research (FMR) 2.21M sh · $45.72M · Q2 2026
- Goldman Sachs Group 1.77M sh · $36.69M · Q2 2026
- Geode Capital Management 1.50M sh · $30.98M · Q2 2026
- Morgan Stanley 1.07M sh · $22.14M · Q2 2026
- Charles Schwab Investment Management 998.63K sh · $20.67M · Q2 2026
- Millennium Management 803.32K sh · $16.63M · Q2 2026
- Northern Trust Corp 671.77K sh · $13.91M · Q2 2026
- Royce & Associates 662.18K sh · $13.71M · Q2 2026
- AQR Capital Management 590.65K sh · $12.23M · Q2 2026